Pharmaceuticals
Within the highly competitive pharmaceutical industry companies are constantly seeking efficiencies in marketing, manufacturing and research. They also require the flexibility to conform to regulatory pressures demanded by increased accountability in the global pharmaceuticals market.
In this sector, Cornwell is focussed on assisting pharmaceutical and consumer healthcare organisations to maximise their commercial returns. Our solutions address the key issues including those of declining research and development and sales force productivity with services including:
- Electronic records management and 21 CFR Part 11 compliance – Good information management is a critical in an industry reliant on innovation for growth, and is imperative for regulatory compliance. Cornwell is the leading independent adviser on electronic records management and acknowledged as thought-leaders in various aspects of ERM compliance including 21 CFR Part 11 compliance. Our team of specialist consultants help create a compliance plan that addresses processes and people, as well as technology. We use a risk-based approach to compliance to ensure manufacturing innovation and technological advances are not hindered.
Our service addresses:
- Electronic record requirements
- Electronic signature requirements
- Audit trails and data integrity
- Impact of legacy systems
- Competitive supply chain resilience(CSCR) – The management, prequalification and assessment of suppliers is of critical importance in the pharmaceutical sector. Our consultants assist in identifying the key supply chain (and wider supply network) processes and classify them using a method that links to business strategy. This enables vulnerability within the supply chain processes to be identified and prioritised. Then improvement projects and potential scenarios can be identified and an effective business case produced.
For further information please click here to complete an Information Request Form.
Top
Home